Researchers explore the effects of the urban environment on adult mental health.
Clearmind Medicine Completed Type A Meeting with the FDA | Psychedelic Invest
Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to